Molecular Diagnostics

Widespread increase of infectious diseases and growing geriatric population base are driving the demand for molecular diagnostics tools and technologies. Rising demand for rapid and remote healthcare delivery and introduction of favorable regulatory initiatives are slated to boost the molecular diagnostics sector.

Our experts at Aranca have significant domain expertise, especially in the areas of extraction & preservation tools, techniques, reagents, sample processing tools, detection tools etc., and have more than 250,000 man-hours of research experience. Covering over 400 diagnostics and reagents, our consultants are fully equipped to help our clients closely track the sector and figure best ways to do white space analysis, understand R&D roadmaps, ascertain patent monetization trends, follow technology innovation, and much more.  

Track Record

350+ Molecular Diagnostic Projects conducted


Projects conducted.

400+  Diagnostic devices and reagents covered


Diagnostic devices and reagents covered by our consultants.

30+ Molecular Diagnostic Clients


Clients including diagnostic players, Pharma, and Biotech companies.

250,000+ Man hours of Molecular Diagnostic's IP research experience


Man hours of research experience.

Domain Expertise

Significant breadth and depth of experience across the Molecular Diagnostics domain.

Extraction/ Preservation Tools

  • Centrifuge
  • Magnetic Stirrer / Sorter
  • Ultra-Freezers
  • Filtration Units
  • Autoclave / Sterilizer

Sample Processing Tools

  • Microtiter Plates
  • Pipettes/ Micro Pipettes
  • Reactors
  • Incubators
  • Cryostat

Detection Tools

  • Chromatograph
  • Microarrays / MEMS Chips
  • DNA Fingerprinting Devices
  • Gene Sequencers
  • PCR Units


  • Genomic DNA
  • Genomic RNA
  • Polymorphic Genes
  • 16s rRNA
  • ssRNA


  • FISH
  • Hybridization
  • Pyrosequencing
  • Sequencing by Synthesis


  • Fluorescent Dyes
  • Enzymes
  • Immobilised antibody / antigens
  • Primers
  • Probes

Examples of Our Work in Molecular Diagnostics

Technology Intelligence

R&D Strategy Roadmaps

  • Consumer demand analysis for conceptualizing new product/ ideas related to PCR filter plates
  • Technology adoption assessment for Optical biosensors in molecular diagnostics market
  • New material identification for innovation in diagnostic kit substrate

White Space Analysis

  • Gap analysis for current signal amplification technologies used in POC kits, to detect infectious agents
  • TPLC study for cryostat devices in DNA amplification
  • Incremental product innovation identification and feasibility evaluation for Portable Diagnostics in NASA mission

Technology Landscape | Innovation Focus

  • Identification of emerging molecular testing techniques and product analysis for prenatal screening market
  • Technology landscape study on gas chromatography detectors
  • R&D trend identification in domain of array based tuberculosis diagnosis

Monetizing Existing Technical Know-how

  • Technology valuation support for a patent portfolio related to blotting membranes used in diagnostic applications
  • New application identification for electrochemical sensors technology in cancer diagnostics
  • Feasibility assessment of a product for DNA fingerprinting based on thermal cycling technology

Technology Scouting and Acquisition

  • Acquisition target identification for fluorescence system manufacturer
  • Technology scouting for non-PCR target amplification methods used in molecular diagnostics
  • Feasibility analysis of filtering techniques in fluorescence microscopy

Product Design for Emerging Technologies/ Markets

  • Commercialization potential identification for launch of new color detection module on pipette station
  • New technology identification for reducing power consumption in thermocycler devices
  • Identification of problems and researched solutions to conceptualize product on Internet of Things enabled biochips

IP Strategy

Prosecution Support

  • Patentability study for PCR filter plates
  • Novelty search for invention related to modifying & analyzing the modified N-terminal protein
  • Patent drafting for a device and method to manufacture an active transponder in biochip

Prior Art Searches

  • FTO study for specific reagents used in PCR mix
  • IP risk assessment study related to antibody coating method on diagnostic array device
  • Invalidation study for a patent related to PCR devices

Portfolio Analysis

  • Identifying sequencers and mapping them with claims of a patent to assess the extent of overlap
  • Patent quality assessment for a portfolio related to nucleic acid probes
  • Key patents identification for licensing purpose from portfolio related to PCR kits

Technology/ Patent Landscape

  • Competitors’ blocking IP identification study, related to metal electrode technology used in MEMS chips and evaluating patent landscape to develop fencing around
  • Patent landscape study to identify various applications of CAR-T cells in molecular diagnostics
  • Technology landscape on next generation sequencing techniques

Licensing Program Support

  • Potential companies identification for out-licensing portfolio related to reagent dispensing systems used in pipetting stations
  • Licensing opportunity assessment for invention related to micropipette barcode reader
  • Target products identification related to manufacturing device for protein microarray

M&A Support

  • Due-diligence of IP portfolio of FRET labels probes used in PCR reactions
  • Identification of restriction enzyme manufacturer, synergistic with diagnostic kit provider, for potential IP acquisition
  • Patent portfolio SWOT analysis for two cell sorter manufacturers

Looking for help with Technology Intelligence, IP Strategy, or Litigation support?

Knowledge Library

  1. 1
  2. 2
  3. 3
  1. 2
  2. 3
  1. CRISPR/Cas9 – Market Players Snapshot

    We're entering a new era in molecular biology. A new tool based on a bacterial CRISPR-associated protein-9 nuclease (Cas9) from Streptococcus pyogenes will enable the

  2. 2
  1. 2
  2. Cardiac Nuclear Imaging and Radiotracers

    Recent novel radiopharmaceuticals agents developed to target specific subcellular process are capable of significantly improving diagnostic accuracy and prognostic evaluation. The global nuclear medicine diagnostic